GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 131 filers reported holding GENMAB A/S in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $221,072 | -1.9% | 6,268 | +5.7% | 0.00% | – |
Q2 2023 | $225,437 | +12.0% | 5,931 | +11.3% | 0.00% | – |
Q1 2023 | $201,260 | -14.7% | 5,330 | -4.1% | 0.00% | – |
Q4 2022 | $236,000 | +15.1% | 5,558 | -2.0% | 0.00% | – |
Q1 2022 | $205,000 | -58.5% | 5,669 | -54.6% | 0.00% | – |
Q4 2021 | $494,000 | +93.7% | 12,481 | +113.1% | 0.00% | – |
Q3 2021 | $255,000 | +10.9% | 5,858 | +4.1% | 0.00% | – |
Q2 2021 | $230,000 | -0.9% | 5,626 | -20.1% | 0.00% | – |
Q1 2021 | $232,000 | -84.3% | 7,043 | -80.6% | 0.00% | -100.0% |
Q4 2020 | $1,478,000 | +20.3% | 36,367 | +8.4% | 0.00% | – |
Q3 2020 | $1,229,000 | +502.5% | 33,557 | +459.5% | 0.00% | – |
Q2 2020 | $204,000 | -77.1% | 5,998 | -85.7% | 0.00% | – |
Q1 2020 | $891,000 | -3.3% | 42,069 | +1.9% | 0.00% | – |
Q4 2019 | $921,000 | +11.4% | 41,273 | +1.0% | 0.00% | – |
Q3 2019 | $827,000 | +9088.9% | 40,852 | +9080.2% | 0.00% | – |
Q3 2014 | $9,000 | +200.0% | 445 | +256.0% | 0.00% | – |
Q2 2014 | $3,000 | +50.0% | 125 | +7.8% | 0.00% | – |
Q1 2014 | $2,000 | – | 116 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |